Regulation and function of the interleukin 13 receptor alpha 2 during a T helper cell type 2-dominant immune response.

PubWeight™: 2.71‹?› | Rank: Top 1%

🔗 View Article (PMC 2193852)

Published in J Exp Med on March 17, 2003

Authors

Monica G Chiaramonte1, Margaret Mentink-Kane, Bruce A Jacobson, Allen W Cheever, Matthew J Whitters, Mary E P Goad, Anthony Wong, Mary Collins, Debra D Donaldson, Michael J Grusby, Thomas A Wynn

Author Affiliations

1: Immunopathogenesis Section, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.

Articles citing this

Cellular and molecular mechanisms of fibrosis. J Pathol (2008) 14.01

Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm. Nat Immunol (2010) 9.59

Fibrotic disease and the T(H)1/T(H)2 paradigm. Nat Rev Immunol (2004) 6.75

Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases. J Clin Invest (2007) 6.56

Mechanisms of fibrosis: therapeutic translation for fibrotic disease. Nat Med (2012) 6.15

Arginase-1-expressing macrophages suppress Th2 cytokine-driven inflammation and fibrosis. PLoS Pathog (2009) 4.12

Suppression of allergic airway inflammation by helminth-induced regulatory T cells. J Exp Med (2005) 3.63

Integrating mechanisms of pulmonary fibrosis. J Exp Med (2011) 3.57

The IL-21 receptor augments Th2 effector function and alternative macrophage activation. J Clin Invest (2006) 3.33

Immunopathology of schistosomiasis. Immunol Cell Biol (2006) 2.74

Enhanced interleukin (IL)-13 responses in mice lacking IL-13 receptor alpha 2. J Exp Med (2003) 2.54

Unique functions of the type II interleukin 4 receptor identified in mice lacking the interleukin 13 receptor alpha1 chain. Nat Immunol (2007) 2.50

Host responses in tissue repair and fibrosis. Annu Rev Pathol (2012) 2.10

Distinct roles for IL-13 and IL-4 via IL-13 receptor alpha1 and the type II IL-4 receptor in asthma pathogenesis. Proc Natl Acad Sci U S A (2008) 2.06

A role for sex chromosome complement in the female bias in autoimmune disease. J Exp Med (2008) 1.96

Th2 Cytokines and Atopic Dermatitis. J Clin Cell Immunol (2011) 1.91

Importance of cytokines in murine allergic airway disease and human asthma. J Immunol (2010) 1.86

IL-13 receptor alpha 2 down-modulates granulomatous inflammation and prolongs host survival in schistosomiasis. Proc Natl Acad Sci U S A (2003) 1.80

Molecular basis for shared cytokine recognition revealed in the structure of an unusually high affinity complex between IL-13 and IL-13Ralpha2. Structure (2010) 1.79

Blockade of transforming growth factor-beta1 accelerates lymphatic regeneration during wound repair. Am J Pathol (2010) 1.77

Type 2 cytokines: mechanisms and therapeutic strategies. Nat Rev Immunol (2015) 1.57

On the hunt for helminths: innate immune cells in the recognition and response to helminth parasites. Cell Microbiol (2008) 1.50

IL-13Ralpha2 and IL-10 coordinately suppress airway inflammation, airway-hyperreactivity, and fibrosis in mice. J Clin Invest (2007) 1.47

Gene profiling of keloid fibroblasts shows altered expression in multiple fibrosis-associated pathways. J Invest Dermatol (2007) 1.38

Schistosomiasis-induced experimental pulmonary hypertension: role of interleukin-13 signaling. Am J Pathol (2010) 1.33

Macrophage activation governs schistosomiasis-induced inflammation and fibrosis. Eur J Immunol (2011) 1.31

Lysophosphatidic acid signaling in airway epithelium: role in airway inflammation and remodeling. Cell Signal (2008) 1.28

Functional importance of regional differences in localized gene expression of receptors for IL-13 in murine gut. J Immunol (2006) 1.26

Restoration of tumor immunosurveillance via targeting of interleukin-13 receptor-alpha 2. Cancer Res (2008) 1.26

Emerging functions of amphiregulin in orchestrating immunity, inflammation, and tissue repair. Immunity (2015) 1.26

Chitinase 3-like 1 regulates cellular and tissue responses via IL-13 receptor α2. Cell Rep (2013) 1.24

Tissue remodeling in eosinophilic esophagitis. Am J Physiol Gastrointest Liver Physiol (2012) 1.20

Cationic amino acid transporter-2 regulates immunity by modulating arginase activity. PLoS Pathog (2008) 1.19

Association of type 2 cytokines with hepatic fibrosis in human Schistosoma mansoni infection. Infect Immun (2004) 1.15

Th2 signals induce epithelial injury in mice and are compatible with the biliary atresia phenotype. J Clin Invest (2011) 1.13

IL-13 receptor alpha2 regulates the immune and functional response to Nippostrongylus brasiliensis infection. J Immunol (2009) 1.13

Cytokine mediated tissue fibrosis. Biochim Biophys Acta (2012) 1.06

Cytokine production associated with periportal fibrosis during chronic schistosomiasis mansoni in humans. Infect Immun (2006) 1.05

Accelerated and progressive and lethal liver fibrosis in mice that lack interleukin (IL)-10, IL-12p40, and IL-13Rα2. Gastroenterology (2011) 1.05

Interleukin-13 and its receptors in idiopathic interstitial pneumonia: clinical implications for lung function. J Korean Med Sci (2009) 1.04

Cytokines mediating the induction of chronic colitis and colitis-associated fibrosis. Mucosal Immunol (2008) 1.01

Lysophosphatidic acid induces interleukin-13 (IL-13) receptor alpha2 expression and inhibits IL-13 signaling in primary human bronchial epithelial cells. J Biol Chem (2007) 1.00

A novel and sensitive ELISA reveals that the soluble form of IL-13R-alpha2 is not expressed in plasma of healthy or asthmatic subjects. Clin Exp Allergy (2008) 0.99

Transcriptional profiling of the bladder in urogenital schistosomiasis reveals pathways of inflammatory fibrosis and urothelial compromise. PLoS Negl Trop Dis (2012) 0.98

MicroRNA-gene expression network in murine liver during Schistosoma japonicum infection. PLoS One (2013) 0.97

Incomplete deletion of IL-4Rα by LysM(Cre) reveals distinct subsets of M2 macrophages controlling inflammation and fibrosis in chronic schistosomiasis. PLoS Pathog (2014) 0.96

Differential liver protein expression during schistosomiasis. Infect Immun (2006) 0.95

Targeting interleukin-13 with tralokinumab attenuates lung fibrosis and epithelial damage in a humanized SCID idiopathic pulmonary fibrosis model. Am J Respir Cell Mol Biol (2014) 0.94

Interleukin-13 (IL-13)/IL-13 receptor alpha1 (IL-13Ralpha1) signaling regulates intestinal epithelial cystic fibrosis transmembrane conductance regulator channel-dependent Cl- secretion. J Biol Chem (2011) 0.94

Coxiella burnetii, the agent of Q fever, replicates within trophoblasts and induces a unique transcriptional response. PLoS One (2010) 0.93

IL-13R alpha 2 membrane and soluble isoforms differ in humans and mice. J Immunol (2009) 0.92

IL-13Rα2 has a protective role in a mouse model of cutaneous inflammation. J Immunol (2010) 0.92

miR-142-5p and miR-130a-3p are regulated by IL-4 and IL-13 and control profibrogenic macrophage program. Nat Commun (2015) 0.91

Interleukin-10 (IL-10) counterregulates IL-4-dependent effector mechanisms in Murine Filariasis. Infect Immun (2004) 0.91

Silencing IL-13Rα2 promotes glioblastoma cell death via endogenous signaling. Mol Cancer Ther (2011) 0.90

Matrix metalloproteinase 8 contributes to solubilization of IL-13 receptor alpha2 in vivo. J Allergy Clin Immunol (2008) 0.88

IL-13 Signaling in Liver Fibrogenesis. Front Immunol (2012) 0.88

MAPK regulation of IL-4/IL-13 receptors contributes to the synergistic increase in CCL11/eotaxin-1 in response to TGF-β1 and IL-13 in human airway fibroblasts. J Immunol (2012) 0.87

Decoy receptors in the regulation of T helper cell type 2 responses. J Exp Med (2003) 0.87

The Causal Role of IL-4 and IL-13 in Schistosoma mansoni Pulmonary Hypertension. Am J Respir Crit Care Med (2015) 0.86

Systemic effector and regulatory immune responses to chlamydial antigens in trachomatous trichiasis. Front Microbiol (2011) 0.86

Glioma IL13Rα2 is associated with mesenchymal signature gene expression and poor patient prognosis. PLoS One (2013) 0.83

The immune pathogenesis of scleroderma: context is everything. Curr Rheumatol Rep (2013) 0.83

Silymarin reduces profibrogenic cytokines and reverses hepatic fibrosis in chronic murine schistosomiasis. Antimicrob Agents Chemother (2014) 0.82

A novel data mining system points out hidden relationships between immunological markers in multiple sclerosis. Immun Ageing (2013) 0.82

Modulation of exaggerated-IgE allergic responses by gene transfer-mediated antagonism of IL-13 and IL-17e. Mol Ther (2009) 0.80

Interleukin-13 and its receptors in colorectal cancer (Review). Biomed Rep (2013) 0.80

Chitinase 3-like-1 and its receptors in Hermansky-Pudlak syndrome-associated lung disease. J Clin Invest (2015) 0.80

Negative regulation of Schistosoma japonicum egg-induced liver fibrosis by natural killer cells. PLoS Negl Trop Dis (2012) 0.78

IL-13 is a therapeutic target in radiation lung injury. Sci Rep (2016) 0.78

Enhanced protection from fibrosis and inflammation in the combined absence of IL-13 and IFN-γ. J Pathol (2016) 0.77

Deficiency in Th2 cytokine responses exacerbate orthopoxvirus infection. PLoS One (2015) 0.77

Commentary: IL-4 and IL-13 receptors and signaling. Cytokine (2015) 0.77

Immunomodulatory effect of R848 on cytokine production associated with Schistosoma mansoni infection. Parasitol Res (2012) 0.77

Interleukin-13 Activates Distinct Cellular Pathways Leading to Ductular Reaction, Steatosis, and Fibrosis. Immunity (2016) 0.76

Schistosomiasis-associated pulmonary hypertension. Pulm Circ (2014) 0.76

IL-13Rα2 uses TMEM219 in chitinase 3-like-1-induced signalling and effector responses. Nat Commun (2016) 0.76

Macrophage and Innate Lymphoid Cell Interplay in the Genesis of Fibrosis. Front Immunol (2015) 0.76

Differential effects of peptidoglycan on colorectal tumors and intestinal tissue post-pelvic radiotherapy. Oncotarget (2016) 0.75

IL-17A enhances IL-13 activity by enhancing IL-13-induced signal transducer and activator of transcription 6 activation. J Allergy Clin Immunol (2016) 0.75

Site-specific gene expression profiling as a novel strategy for unravelling keloid disease pathobiology. PLoS One (2017) 0.75

Transgenic modelling of cytokine polarization in the lung. Immunology (2010) 0.75

Monocyte subsets in schistosomiasis patients with periportal fibrosis. Mediators Inflamm (2014) 0.75

IL-13/STAT6 signaling plays a critical role in the epithelial-mesenchymal transition of colorectal cancer cells. Oncotarget (2016) 0.75

Pleiotropic Effects of Immune Responses Explain Variation in the Prevalence of Fibroproliferative Diseases. PLoS Genet (2015) 0.75

Negative Regulation of Type 2 Immunity. Trends Immunol (2017) 0.75

Articles cited by this

Interleukin-13: central mediator of allergic asthma. Science (1998) 14.05

Requirement for IL-13 independently of IL-4 in experimental asthma. Science (1998) 10.76

Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production. J Clin Invest (1999) 8.38

Stat6 is required for mediating responses to IL-4 and for development of Th2 cells. Immunity (1996) 8.16

The IL-4 receptor: signaling mechanisms and biologic functions. Annu Rev Immunol (1999) 6.19

In the absence of endogenous IL-10, mice acutely infected with Toxoplasma gondii succumb to a lethal immune response dependent on CD4+ T cells and accompanied by overproduction of IL-12, IFN-gamma and TNF-alpha. J Immunol (1996) 5.79

NKT cell-mediated repression of tumor immunosurveillance by IL-13 and the IL-4R-STAT6 pathway. Nat Immunol (2000) 4.75

Anti-inflammatory cytokines. Chest (2000) 4.74

Interleukin-13 induces tissue fibrosis by selectively stimulating and activating transforming growth factor beta(1). J Exp Med (2001) 4.71

IL-13, IL-4Ralpha, and Stat6 are required for the expulsion of the gastrointestinal nematode parasite Nippostrongylus brasiliensis. Immunity (1998) 4.65

Interleukin-2 receptor gamma chain: a functional component of the interleukin-4 receptor. Science (1993) 4.63

Recombinant human interleukin 5 is a selective activator of human eosinophil function. J Exp Med (1988) 4.60

Differential regulation of nitric oxide synthase-2 and arginase-1 by type 1/type 2 cytokines in vivo: granulomatous pathology is shaped by the pattern of L-arginine metabolism. J Immunol (2001) 4.59

Tumour necrosis factor alpha restores granulomas and induces parasite egg-laying in schistosome-infected SCID mice. Nature (1992) 4.57

An IL-13 inhibitor blocks the development of hepatic fibrosis during a T-helper type 2-dominated inflammatory response. J Clin Invest (1999) 4.22

Advanced multiplexed analysis with the FlowMetrix system. Clin Chem (1997) 4.03

The germless theory of allergic disease: revisiting the hygiene hypothesis. Nat Rev Immunol (2001) 3.98

Egg deposition is the major stimulus for the production of Th2 cytokines in murine schistosomiasis mansoni. J Immunol (1991) 3.65

Interleukin-1 type II receptor: a decoy target for IL-1 that is regulated by IL-4. Science (1993) 3.62

Analysis of cytokine mRNA expression during primary granuloma formation induced by eggs of Schistosoma mansoni. J Immunol (1993) 3.34

Anti-cytokine antibodies as carrier proteins. Prolongation of in vivo effects of exogenous cytokines by injection of cytokine-anti-cytokine antibody complexes. J Immunol (1993) 3.29

A distinct role for interleukin-13 in Th2-cell-mediated immune responses. Curr Biol (1998) 3.19

Reciprocal regulation of the nitric oxide synthase/arginase balance in mouse bone marrow-derived macrophages by TH1 and TH2 cytokines. Eur J Immunol (1995) 3.17

IL-10 and the dangers of immune polarization: excessive type 1 and type 2 cytokine responses induce distinct forms of lethal immunopathology in murine schistosomiasis. J Immunol (2000) 3.03

Endogenous interleukin 12 (IL-12) regulates granuloma formation induced by eggs of Schistosoma mansoni and exogenous IL-12 both inhibits and prophylactically immunizes against egg pathology. J Exp Med (1994) 2.99

Schistosome infection of transgenic mice defines distinct and contrasting pathogenic roles for IL-4 and IL-13: IL-13 is a profibrotic agent. J Immunol (2000) 2.89

Critical role for IL-13 in the development of allergen-induced airway hyperreactivity. J Immunol (2001) 2.63

Cloning and characterization of a binding subunit of the interleukin 13 receptor that is also a component of the interleukin 4 receptor. Proc Natl Acad Sci U S A (1996) 2.57

The murine IL-13 receptor alpha 2: molecular cloning, characterization, and comparison with murine IL-13 receptor alpha 1. J Immunol (1998) 2.57

Enhanced interleukin (IL)-13 responses in mice lacking IL-13 receptor alpha 2. J Exp Med (2003) 2.54

Overlapping and enzyme-specific contributions of matrix metalloproteinases-9 and -12 in IL-13-induced inflammation and remodeling. J Clin Invest (2002) 2.52

An IL-12-based vaccination method for preventing fibrosis induced by schistosome infection. Nature (1995) 2.52

A critical role for IL-13 in resistance to intestinal nematode infection. J Immunol (1998) 2.50

IL-10 is required to prevent immune hyperactivity during infection with Trypanosoma cruzi. J Immunol (1997) 2.50

Activation of hepatic stellate cells--a key issue in liver fibrosis. Front Biosci (2002) 2.49

Anti-IL-4 treatment of Schistosoma mansoni-infected mice inhibits development of T cells and non-B, non-T cells expressing Th2 cytokines while decreasing egg-induced hepatic fibrosis. J Immunol (1994) 2.25

Th2 cells are required for the Schistosoma mansoni egg-induced granulomatous response. J Immunol (1998) 2.20

IL-4 protects against TNF-alpha-mediated cachexia and death during acute schistosomiasis. J Immunol (1997) 2.09

Strain-specific differences in mouse hepatic wound healing are mediated by divergent T helper cytokine responses. Proc Natl Acad Sci U S A (1997) 2.03

Elevated serum levels of interleukin 4 (IL-4), IL-10, and IL-13 in patients with systemic sclerosis. J Rheumatol (1997) 1.95

IL-13 is a key regulatory cytokine for Th2 cell-mediated pulmonary granuloma formation and IgE responses induced by Schistosoma mansoni eggs. J Immunol (1999) 1.91

Studies of murine schistosomiasis reveal interleukin-13 blockade as a treatment for established and progressive liver fibrosis. Hepatology (2001) 1.90

Schistosome-infected IL-4 receptor knockout (KO) mice, in contrast to IL-4 KO mice, fail to develop granulomatous pathology while maintaining the same lymphokine expression profile. J Immunol (1999) 1.78

Development of an assay to measure in vivo cytokine production in the mouse. Int Immunol (1999) 1.68

NOS-2 mediates the protective anti-inflammatory and antifibrotic effects of the Th1-inducing adjuvant, IL-12, in a Th2 model of granulomatous disease. Am J Pathol (2000) 1.67

The interleukin-13 receptor alpha2 chain: an essential component for binding and internalization but not for interleukin-13-induced signal transduction through the STAT6 pathway. Blood (2001) 1.61

Cloning of the human IL-13R alpha1 chain and reconstitution with the IL4R alpha of a functional IL-4/IL-13 receptor complex. FEBS Lett (1997) 1.57

Regulation of hepatic fibrosis and extracellular matrix genes by the th response: new insight into the role of tissue inhibitors of matrix metalloproteinases. J Immunol (2001) 1.55

Studies with double cytokine-deficient mice reveal that highly polarized Th1- and Th2-type cytokine and antibody responses contribute equally to vaccine-induced immunity to Schistosoma mansoni. J Immunol (1999) 1.53

A type 2 (Th2-like) pattern of immune response predominates in the pulmonary interstitium of patients with cryptogenic fibrosing alveolitis (CFA). Clin Exp Immunol (1995) 1.50

Cloning and characterization of a specific interleukin (IL)-13 binding protein structurally related to the IL-5 receptor alpha chain. J Biol Chem (1996) 1.43

Cytokine regulation of granuloma formation in schistosomiasis. Curr Opin Immunol (1995) 1.36

Schistosoma mansoni in IL-4-deficient mice. Int Immunol (1996) 1.32

Disease fingerprinting with cDNA microarrays reveals distinct gene expression profiles in lethal type 1 and type 2 cytokine-mediated inflammatory reactions. FASEB J (2001) 1.30

Identification, purification, and characterization of a soluble interleukin (IL)-13-binding protein. Evidence that it is distinct from the cloned Il-13 receptor and Il-4 receptor alpha-chains. J Biol Chem (1997) 1.28

Analysis of granuloma formation in double cytokine-deficient mice reveals a central role for IL-10 in polarizing both T helper cell 1- and T helper cell 2-type cytokine responses in vivo. J Immunol (1997) 1.23

The role of IL-13 in helminth-induced inflammation and protective immunity against nematode infections. Curr Opin Immunol (1999) 1.22

Structure of and signal transduction through interleukin-4 and interleukin-13 receptors (review). Int J Mol Med (1998) 1.21

Variation of hepatic fibrosis and granuloma size among mouse strains infected with Schistosoma mansoni. Am J Trop Med Hyg (1987) 1.18

Different cytokine profiles in cryptogenic fibrosing alveolitis and fibrosing alveolitis associated with systemic sclerosis: a quantitative study of open lung biopsies. Eur Respir J (1999) 1.15

Chronic allograft rejection. Do the Th2 cells preferentially induced by indirect alloantigen recognition play a dominant role? Transplantation (1999) 1.13

A novel mechanism by which interferon-gamma can regulate interleukin (IL)-13 responses. Evidence for intracellular stores of IL-13 receptor alpha -2 and their rapid mobilization by interferon-gamma. J Biol Chem (2002) 1.12

Infection of mice lacking interleukin-7 (IL-7) reveals an unexpected role for IL-7 in the development of the parasite Schistosoma mansoni. Infect Immun (1999) 1.08

Th2 cells as effectors in postirradiation pulmonary damage preceding fibrosis in the rat. Int J Radiat Biol (1999) 1.07

The interleukin-4/interleukin-13 receptor of human synovial fibroblasts: overexpression of the nonsignaling interleukin-13 receptor alpha2. Lab Invest (1998) 1.07

IL-13-mediated worm expulsion is B7 independent and IFN-gamma sensitive. J Immunol (2000) 1.07

Elevated type 1, diminished type 2 cytokines and impaired antibody response are associated with hepatotoxicity and mortalities during Schistosoma mansoni infection of CD4-depleted mice. Eur J Immunol (2000) 0.99

PCR analysis of cytokine induction profiles associated with mouse strain variation in susceptibility to pulmonary fibrosis. Reg Immunol (1993) 0.99

Experimental production of bilharzial pipe-stem fibrosis in the chimpanzee. Exp Parasitol (1968) 0.94

Expression of interleukin 13 receptor in glioma and renal cell carcinoma: IL13Ralpha2 as a decoy receptor for IL13. Lab Invest (2001) 0.93

Effects of IL-13 on airway responses in the guinea pig. Am J Physiol Lung Cell Mol Physiol (2002) 0.84

Pipe-stem fibrosis of the liver. Trans R Soc Trop Med Hyg (1972) 0.84

Articles by these authors

High-Throughput GoMiner, an 'industrial-strength' integrative gene ontology tool for interpretation of multiple-microarray experiments, with application to studies of Common Variable Immune Deficiency (CVID). BMC Bioinformatics (2005) 14.02

Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides. J Exp Med (2006) 13.74

Protective and pathogenic functions of macrophage subsets. Nat Rev Immunol (2011) 12.21

CD4(+)CD25(+) immunoregulatory T cells: gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor. Immunity (2002) 8.28

Essential role of NKT cells producing IL-4 and IL-13 in the development of allergen-induced airway hyperreactivity. Nat Med (2003) 6.42

Chronic mucocutaneous candidiasis in humans with inborn errors of interleukin-17 immunity. Science (2011) 6.19

IL-23 plays a key role in Helicobacter hepaticus-induced T cell-dependent colitis. J Exp Med (2006) 5.76

Conventional T-bet(+)Foxp3(-) Th1 cells are the major source of host-protective regulatory IL-10 during intracellular protozoan infection. J Exp Med (2007) 4.47

Transforming growth factor-beta production and myeloid cells are an effector mechanism through which CD1d-restricted T cells block cytotoxic T lymphocyte-mediated tumor immunosurveillance: abrogation prevents tumor recurrence. J Exp Med (2003) 4.33

Toll-like receptor-induced arginase 1 in macrophages thwarts effective immunity against intracellular pathogens. Nat Immunol (2008) 4.31

Arginase-1-expressing macrophages suppress Th2 cytokine-driven inflammation and fibrosis. PLoS Pathog (2009) 4.12

IL-22 is required for Th17 cell-mediated pathology in a mouse model of psoriasis-like skin inflammation. J Clin Invest (2008) 4.12

PD-1:PD-L inhibitory pathway affects both CD4(+) and CD8(+) T cells and is overcome by IL-2. Eur J Immunol (2002) 3.78

Regulation of muscle growth by multiple ligands signaling through activin type II receptors. Proc Natl Acad Sci U S A (2005) 3.52

Bleomycin and IL-1beta-mediated pulmonary fibrosis is IL-17A dependent. J Exp Med (2010) 3.44

Effect of clinical decision-support systems: a systematic review. Ann Intern Med (2012) 3.42

The B7 family of ligands and its receptors: new pathways for costimulation and inhibition of immune responses. Annu Rev Immunol (2001) 3.41

The IL-21 receptor augments Th2 effector function and alternative macrophage activation. J Clin Invest (2006) 3.33

IL-21 limits NK cell responses and promotes antigen-specific T cell activation: a mediator of the transition from innate to adaptive immunity. Immunity (2002) 3.17

Obstacles and opportunities for understanding macrophage polarization. J Leukoc Biol (2011) 3.16

Engagement of glucocorticoid-induced TNFR family-related receptor on effector T cells by its ligand mediates resistance to suppression by CD4+CD25+ T cells. J Immunol (2004) 3.15

Phenotypic and functional plasticity of cells of innate immunity: macrophages, mast cells and neutrophils. Nat Immunol (2011) 2.92

CD4+ T cells mediate abscess formation in intra-abdominal sepsis by an IL-17-dependent mechanism. J Immunol (2003) 2.79

Immunopathology of schistosomiasis. Immunol Cell Biol (2006) 2.74

IL-21 has a pathogenic role in a lupus-prone mouse model and its blockade with IL-21R.Fc reduces disease progression. J Immunol (2007) 2.71

A crucial role for the vitamin D receptor in experimental inflammatory bowel diseases. Mol Endocrinol (2003) 2.69

An essential role for TH2-type responses in limiting acute tissue damage during experimental helminth infection. Nat Med (2012) 2.60

Bacteria-triggered CD4(+) T regulatory cells suppress Helicobacter hepaticus-induced colitis. J Exp Med (2002) 2.60

Abrogation of Ref1 retrovirus restriction in human cells. J Virol (2002) 2.60

Enhanced interleukin (IL)-13 responses in mice lacking IL-13 receptor alpha 2. J Exp Med (2003) 2.54

The pathogenesis of schistosomiasis is controlled by cooperating IL-10-producing innate effector and regulatory T cells. J Immunol (2004) 2.50

Unique functions of the type II interleukin 4 receptor identified in mice lacking the interleukin 13 receptor alpha1 chain. Nat Immunol (2007) 2.50

Global gene expression profiles during acute pathogen-induced pulmonary inflammation reveal divergent roles for Th1 and Th2 responses in tissue repair. J Immunol (2003) 2.48

IL-13 activates a mechanism of tissue fibrosis that is completely TGF-beta independent. J Immunol (2004) 2.47

An IL-17F/A heterodimer protein is produced by mouse Th17 cells and induces airway neutrophil recruitment. J Immunol (2007) 2.46

PDLIM2-mediated termination of transcription factor NF-kappaB activation by intranuclear sequestration and degradation of the p65 subunit. Nat Immunol (2007) 2.45

Regulation of pathogenesis and immunity in helminth infections. J Exp Med (2009) 2.39

Development and characterization of IL-21-producing CD4+ T cells. J Exp Med (2008) 2.34

Interleukin 21 is a T helper (Th) cell 2 cytokine that specifically inhibits the differentiation of naive Th cells into interferon gamma-producing Th1 cells. J Exp Med (2002) 2.28

Immunopathogenesis of schistosomiasis. Immunol Rev (2004) 2.28

Evolution of Th2 immunity: a rapid repair response to tissue destructive pathogens. PLoS Pathog (2011) 2.25

Intranasal Poly-IC treatment exacerbates tuberculosis in mice through the pulmonary recruitment of a pathogen-permissive monocyte/macrophage population. J Clin Invest (2010) 2.22

Putting evidence into practice: evidence-based interventions for chemotherapy-induced peripheral neuropathy. Clin J Oncol Nurs (2007) 2.17

HGF/c-Met acts as an alternative angiogenic pathway in sunitinib-resistant tumors. Cancer Res (2010) 2.11

Blockade of the interleukin-21/interleukin-21 receptor pathway ameliorates disease in animal models of rheumatoid arthritis. Arthritis Rheum (2007) 2.10

Host responses in tissue repair and fibrosis. Annu Rev Pathol (2012) 2.10

Th2 cytokine-induced alterations in intestinal smooth muscle function depend on alternatively activated macrophages. Gastroenterology (2008) 2.09

Retnla (relmalpha/fizz1) suppresses helminth-induced Th2-type immunity. PLoS Pathog (2009) 2.07

Identification of an interleukin 17F/17A heterodimer in activated human CD4+ T cells. J Biol Chem (2007) 2.06

KSHV vFLIP binds to IKK-gamma to activate IKK. J Cell Sci (2003) 2.04

Mice lacking myeloid differentiation factor 88 display profound defects in host resistance and immune responses to Mycobacterium avium infection not exhibited by Toll-like receptor 2 (TLR2)- and TLR4-deficient animals. J Immunol (2003) 2.00

Type 2 immunity and wound healing: evolutionary refinement of adaptive immunity by helminths. Nat Rev Immunol (2013) 1.96

Program death-1 engagement upon TCR activation has distinct effects on costimulation and cytokine-driven proliferation: attenuation of ICOS, IL-4, and IL-21, but not CD28, IL-7, and IL-15 responses. J Immunol (2003) 1.93

SAP regulates T cell-mediated help for humoral immunity by a mechanism distinct from cytokine regulation. J Exp Med (2006) 1.92

MyD88-deficient mice display a profound loss in resistance to Mycobacterium tuberculosis associated with partially impaired Th1 cytokine and nitric oxide synthase 2 expression. Infect Immun (2004) 1.89

Muc5ac: a critical component mediating the rejection of enteric nematodes. J Exp Med (2011) 1.88

Immunoglobulin class switch recombination is impaired in Atm-deficient mice. J Exp Med (2004) 1.87

T(H)-17: a giant step from T(H)1 and T(H)2. Nat Immunol (2005) 1.86

IL-21 inhibits IFN-gamma production in developing Th1 cells through the repression of Eomesodermin expression. J Immunol (2006) 1.86

The human IL-17F/IL-17A heterodimeric cytokine signals through the IL-17RA/IL-17RC receptor complex. J Immunol (2008) 1.82

Duplication of primate and rodent B7-H3 immunoglobulin V- and C-like domains: divergent history of functional redundancy and exon loss. Genomics (2003) 1.81

IL-13 receptor alpha 2 down-modulates granulomatous inflammation and prolongs host survival in schistosomiasis. Proc Natl Acad Sci U S A (2003) 1.80

Resistance of C57BL/6 mice to amoebiasis is mediated by nonhemopoietic cells but requires hemopoietic IL-10 production. J Immunol (2006) 1.77

Interleukin-5 (IL-5) augments the progression of liver fibrosis by regulating IL-13 activity. Infect Immun (2006) 1.76

NK cell-derived IFN-gamma differentially regulates innate resistance and neutrophil response in T cell-deficient hosts infected with Mycobacterium tuberculosis. J Immunol (2006) 1.76

The adaptor protein CIKS/Act1 is essential for IL-25-mediated allergic airway inflammation. J Immunol (2009) 1.76

Th17 cytokines and their emerging roles in inflammation and autoimmunity. Immunol Rev (2008) 1.75

Granulomas in schistosome and mycobacterial infections: a model of local immune responses. Trends Immunol (2003) 1.75

Transforming growth factor-β signaling promotes pulmonary hypertension caused by Schistosoma mansoni. Circulation (2013) 1.68

Chitinase dependent control of protozoan cyst burden in the brain. PLoS Pathog (2012) 1.68